<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:thr="http://purl.org/syndication/thread/1.0">
    <title>Vascular Device Forum</title>
    
    <link rel="hub" href="http://hubbub.api.typepad.com/" />
    <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/" />
    <id>tag:typepad.com,2003:weblog-1398751</id>
    <updated>2010-03-01T13:36:55-08:00</updated>
    <subtitle>Vascular Device Forum (VDF) provides a convenient medium for the discussion of various peripheral and coronary medical devices. We encourage visitors to provide personal comments to make this a very interactive and informative daily experience. 

"Usually fact, Sometimes Opinion, Always Informative"</subtitle>
    <generator uri="http://www.typepad.com/">TypePad</generator>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/VascularDeviceForum" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="vasculardeviceforum" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><entry>
        <title>Long awaited CREST data suggest equivalence between stenting and surgery</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/03/long-awaited-crest-data-suggest-equivalence-between-stenting-and-surgery.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/03/long-awaited-crest-data-suggest-equivalence-between-stenting-and-surgery.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a8e81b29970b</id>
        <published>2010-03-01T13:36:55-08:00</published>
        <updated>2010-03-01T13:36:55-08:00</updated>
        <summary>February 26, 2010—Long-awaited results from the CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) study were presented today for the first time at the American Stroke Association’s Annual International Stroke Conference 2010, which convened on February 24–26 in San Antonio, Texas....</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        <category scheme="http://www.sixapart.com/ns/types#category" term="Carotid Angioplasty and Stenting (CAS)" />
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>February 26, 2010—Long-awaited results from the <a href="http://www.clinicaltrials.gov/ct2/show/NCT00004732">CREST</a> (Carotid Revascularization Endarterectomy versus Stenting Trial) study were presented today for the first time at the <a href="http://strokeconference.americanheart.org/portal/strokeconference/sc/">American Stroke Association’s Annual International Stroke Conference 2010</a>, which convened on February 24–26 in San Antonio, Texas. The CREST Executive Committee met recently to take a first look at this very large data set and prepared the manuscript of the outcome results that was presented.</p>
<p>CREST is comparing stent-assisted carotid angioplasty (CAS) to carotid endarterectomy (CEA) for the treatment of carotid artery stenosis to prevent recurrent strokes in those patients who have had a transient ischemic attack (TIA) or a mild stroke within the previous 6 months (symptomatic) and in those patients who have not had any symptoms within the previous 6 months (asymptomatic). The study is sponsored by the <a href="http://www.umdnj.edu/crestweb/">University of Medicine and Dentistry of New Jersey</a> in collaboration with the US National Institute of Neurological Disorders and Stroke (NINDS). Thomas G. Brott, MD, is the principal investigator for CREST.</p>
<p>Enrollment in the CREST study commenced in December 2000 with an anticipated total enrollment of 2,500 patients and a completion date of December 2011 for collection of data for primary outcome measure. The investigators now report that the current data encompass 2,502 patients enrolled at more than 100 centers in North America. More than 80% of the participants had an artery blockage &gt; 70%.</p>
<p><a href="http://www.bmctoday.net/evtoday/2010/02/article.asp?f=crest-data-show-equivalence-between-cas-and-cea" title="CREST data from EV Today">Read more</a></p></div>
</content>


    </entry>
    <entry>
        <title>President Obama struggles with personal addiction</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/03/president-obama-struggles-with-personal-addiction.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/03/president-obama-struggles-with-personal-addiction.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a8e80c34970b</id>
        <published>2010-03-01T13:25:36-08:00</published>
        <updated>2010-03-01T13:25:36-08:00</updated>
        <summary>There is no doubt that the tobacco is one of the most addictive agents known to man, responsible for millions of cumulative deaths, illnessess and cases of disability. The broad antismoking campaign including significant tax increases ("sin tax") have made...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>
<p>There is no doubt that the tobacco is one of the most addictive agents known to man, responsible for millions of cumulative deaths, illnessess and cases of disability. The broad antismoking campaign including significant tax increases ("sin tax") have made some progress in this effort. However, we still have a long way to go. It seems that President Obama also suffers from hyperlipidemia. This is not really vascular device stuff but it may be if the First lady doesn't take some corrective action. We wish the President the best of luck in his personal battle</p>
<div class="off" jquery1267477995755="6" style="FONT-SIZE: 12px; FLOAT: right; MARGIN: auto auto auto 5px; WIDTH: 232px; LINE-HEIGHT: 12px">
<div class="blog-captioned-photo0" jquery1267477995755="5">
<div class="photo-container" jquery1267477995755="4" style="CLEAR: both; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; POSITION: relative; HEIGHT: 213px"><span jquery1267477995755="3"><a href="http://i.usatoday.net/communitymanager/_photos/the-oval/2010/02/28/obama-thumbsx-large.jpg" jquery1267477995755="2" target="_blank"><img alt="" credit="By J. Scott Applewhite, AP" cutline="President Obama after his physical Sunday." height="211" src="http://i.usatoday.net/communitymanager/_photos/the-oval/2010/02/28/obama-thumbsx-inset-community.jpg" style="BORDER-RIGHT: #666 1px solid; BORDER-TOP: #666 1px solid; FLOAT: none; MARGIN: 0px; BORDER-LEFT: #666 1px solid; BORDER-BOTTOM: #666 1px solid" width="230" /></a></span> 
<div class="legend" style="FONT-SIZE: 10px; Z-INDEX: 20; FILTER: alpha(opacity=70); LEFT: 0px; VISIBILITY: hidden; WIDTH: 232px; COLOR: #fff; BOTTOM: 1px; POSITION: absolute; BACKGROUND-COLOR: #000; opacity: 0.7; moz-opacity: 0.7">
<div class="wording" style="MARGIN: 5px; FONT-FAMILY: Arial,Helvetica,sans-serif">President Obama after his physical Sunday.</div></div></div>
<div class="controls">
<div class="label" style="FLOAT: left; WIDTH: 100px"><a href="javascript:void(0)" jquery1267477995755="7" style="PADDING-RIGHT: 0px; PADDING-LEFT: 11px; FONT-SIZE: 10px; BACKGROUND: url(http://i.usatoday.net/_common/_images/caption0.gif) no-repeat left 50%; PADDING-BOTTOM: 0px; COLOR: #666; PADDING-TOP: 0px"><font color="#666666">CAPTION</font></a></div>
<div class="credit" style="FONT-SIZE: 10px; FLOAT: left; WIDTH: 132px; COLOR: #666; TEXT-ALIGN: right">By J. Scott Applewhite, AP</div></div></div></div>It seems President Obama, reformed cigarette smoker, is having trouble completely kicking the habit.
<p />
<p>
<p>Echoing Obama's comments on the tobacco topic in June, spokesman Robert Gibbs said the president still occasionally "falls of the wagon," just like others who have struggled to quit smoking for good.</p>
<p>"The president continues to chew nicotine gum," Gibbs noted. He added that he doesn't know where in the White House the president might go away to sneak a smoke.</p>
<p>"I don't doubt that he would tell you that he wishes once and for all he could wipe away that struggle," Gibbs said. "I know he works on it each and every day."</p>
<p>While Obama sailed through his physical yesterday with high marks, the medical report citing ongoing efforts at smoking "cessation."</p>
<p>The report also cited a spike in Obama's bad cholesterol, meaning Obama will have to cut down on his share of sweets -- no easy task when living in a house with its own pastry chef.</p>
<p>"Look," Gibbs said, "those guys make good desserts over there."</p>
<p>Just because Obama is thin -- 6-1, 180 pounds -- doesn't mean always eats as well as he should, the spokesman added.</p>
<p>By the way, here is the full transcript of what Obama said in June about smoking.</p>
<blockquote>
<p>Q: How many cigarettes a day do you now smoke? Do you smoke alone or in the presence of other people? And do you believe the new law would help you to quit? If so, why?</p>
<p>THE PRESIDENT: Well, first of all, the new law that was put in place is not about me, it's about the next generation of kids coming up. So I think it's fair, Margaret, to just say that you just think it's neat to ask me about my smoking, as opposed to it being relevant to my new law. (Laughter.) But that's fine, I understand. It's an interesting human -- it's an interesting human interest story.</p>
<p>But I've said before that, as a former smoker, I constantly struggle with it. Have I fallen off the wagon sometimes? Yes. Am I a daily smoker, a constant smoker? No. I don't do it in front of my kids, I don't do it in front of my family, and I would say that I am 95 percent cured, but there are times where -- (laughter) -- there are times where I mess up.</p>
<p>And, I mean, I've said this before. I get this question about once every month or so, and I don't know what to tell you, other than the fact that, like folks who go to AA, once you've gone down this path, then it's something you continually struggle with, which is precisely why the legislation we signed was so important, because what we don't want is kids going down that path in the first place. Okay?</p></blockquote>
<p><em>(Posted by David Jackson)</em></p></p></p></div>
</content>


    </entry>
    <entry>
        <title>Risk Of Dialysis Access Failure Reduced By Combination Of Aspirin And Anti-Clotting Drug</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/risk-of-dialysis-access-failure-reduced-by-combination-of-aspirin-and-anti-clotting-drug.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/risk-of-dialysis-access-failure-reduced-by-combination-of-aspirin-and-anti-clotting-drug.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b996883301310f3b50e3970c</id>
        <published>2010-02-25T14:01:59-08:00</published>
        <updated>2010-02-25T14:01:59-08:00</updated>
        <summary>For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        <category scheme="http://www.sixapart.com/ns/types#category" term="Access Management" />
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml">For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC). The study, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, will be published in the May 21, 2009, <em>New England Journal of Medicine</em>. <br /><br />Artery-vein access grafts, called arteriovenous (AV) grafts, fail most often due to narrowing of blood vessels (stenosis) at the graft site and subsequent clotting, which block the flow of blood. A blocked graft cannot be used for dialysis and is a major cause of worsening health in dialysis patients. <br /><br />The DAC trial found that the combination treatment decreased the rate of loss of primary unassisted graft patency - the useful life of a graft before it becomes blocked the first time - by 18 percent and the rate of developing significant stenosis by 28 percent, compared to placebo. Previous smaller clinical trials of anti-clotting therapies failed to show that these drugs improve AV graft patency or that they could be used safely in dialysis patients. <br /><br />"This drug combination provides a modest but important new therapy to keep AV grafts in good working order so patients can get the dialysis they need," said NIDDK Director Griffin P. Rodgers, M.D. "But clearly more research is needed to extend the useful life of AV grafts." <br /><br />A total of 649 participants with new AV grafts were recruited for the trial at 13 clinical sites in the United States and were randomly assigned to treatment with dipyridamole plus aspirin or to a placebo. The trial took place over a period of five years. <br /><br />"Our trial results show that we now have a drug therapy that significantly prolongs the viability of AV grafts," said Bradley S. Dixon, M.D., of the University of Iowa College of Medicine, Iowa City, and lead author of the study. "This is an important step forward as we proceed to develop therapies to improve dialysis patients' quality of life." <br /><br />According to the 2008 U.S. Renal Data System Annual Data Report, more than half a million patients have kidney failure, 70 percent of whom are on dialysis. Costs for kidney failure are more than $30 billion. Annual costs of vascular access-related procedures in the United States have been estimated to exceed $1 billion. <br /><br />Boehringer Ingelheim Pharmaceuticals, Inc. provided the study drugs and placebo at no cost and provided additional funding as well. The company was not involved in the design of the study, the analysis of data, or the preparation of the manuscript. <br /><br />Source: <br />Arthur Stone <br />NIH/National Institute of Diabetes and Digestive and Kidney Diseases</div>
</content>


    </entry>
    <entry>
        <title>Angiogenesis using stem cells shows promise</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/angiogenesis-using-stem-cells-shows-promise.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/angiogenesis-using-stem-cells-shows-promise.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a8b48947970b</id>
        <published>2010-02-19T11:21:00-08:00</published>
        <updated>2010-02-19T11:21:00-08:00</updated>
        <summary>Historically there has been lots of promise about angiogenesis agents however not much to show in terms of practical benefits in a clinically meaningful way. the Dept of Surgery at Grant Medical Center in Columbus Ohio presented their work in...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>Historically there has been lots of promise about angiogenesis agents however not much to show in terms of practical benefits in a clinically meaningful way. the Dept of Surgery at Grant Medical Center in Columbus Ohio presented their work in a recent JVS Here is an exerpt from EV Today</p>
<p>ADULT STEM CELLS FOR ANGIOGENESIS SHOW PROMISE IN TREATING SEVERE PAD</p>
<p>February 11, 2010—Grant Medical Center in Columbus, Ohio announced that results of a clinical trial documenting the outcomes of nine patients who received transplants of adult stem cells were published by Randall W. Franz, MD, et al in the <a href="http://www.jvascsurg.org/article/S0741-5214(09)01606-1/abstract"><em>Journal of Vascular Surgery</em></a> (2009;50:1378–1390). Few options other than amputation exist for some patients with peripheral arterial disease (PAD) and severe anatomical limitations, the investigators noted.</p>
<p>In this prospective study, the investigators presented short-term results of dual-intramuscular and intra-arterial autologous bone marrow mononuclear cell (BM-MNC) implantation for treating patients with severe PAD for whom amputation was considered the only viable treatment option. Baseline 2-week and 3-month evaluations were </p>
<p><a href="http://bmctoday.net/evtoday/2010/02/article.asp?f=adult-stem-cells-for-angiogenesis-show-promise-in-treating-severe-pad">see full story</a></p></div>
</content>


    </entry>
    <entry>
        <title />
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/great-article-from-endovascular-today-on-filter-characteristics--february2010-----before-you-place-that-filter---a-guide-t.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/great-article-from-endovascular-today-on-filter-characteristics--february2010-----before-you-place-that-filter---a-guide-t.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a8b47e37970b</id>
        <published>2010-02-19T07:10:00-08:00</published>
        <updated>2010-02-19T07:10:00-08:00</updated>
        <summary>great article from endovascular today on filter characteristics February 2010 Before You Place That Filter … A guide to IVC filter placement and troubleshooting procedural challenges.by Ulku Cenk TURBA, MD; Saher S. Sabri, MD; Wael E.A. Saad, MD; Auh Whan...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>great article from endovascular today on filter characteristics</p>
<p><a href="index.asp">February 2010</a> </p>
<div id="article_info">
<h1 class="article_title sIFR-replaced"><span class="sIFR-alternate" id="sIFR_replacement_3_alternate">Before You Place That Filter …</span></h1>
<h3 class="sIFR-replaced"><span class="sIFR-alternate" id="sIFR_replacement_0_alternate">A guide to IVC filter placement and troubleshooting procedural challenges.</span></h3>by Ulku Cenk TURBA, MD; Saher S. Sabri, MD; Wael E.A. Saad, MD; Auh Whan Park, MD; John F. Angle, MD; and Alan H. Matsumoto, MD </div>
<br />
<p><a href="/evtoday/pdfs/et0210_feature_matsumoto.pdf" /> </p>
<div id="articletext">
<p>Evidence-based guidelines from the American College of Chest Physicians and Society of Interventional Radiology recommend inferior vena cava (IVC) filter placement in patients with proven venous thromboembolism with a failure of, a contraindication to, or a complication secondary to anticoagulation.<sup><font size="3">1,2</font></sup> However, with the recent availability of retrievable or so-called optional IVC filters, the use of these devices has expanded significantly in patients who are perceived to be at high risk for pulmonary embolism (PE).<sup><font size="3">1</font></sup> In this article, we focus on the anatomical factors, procedural challenges, and complications related to the use of these devices.</p>
<p><a href="http://bmctoday.net/evtoday/2010/02/article.asp?f=before-you-place-that-filter-" target="_blank">read more</a></p>
<br /></div></div>
</content>


    </entry>
    <entry>
        <title>Bill Clinton admitted for chest pain and coronary stents after 2004 operation</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/bill-clinton-admitted-for-chest-pain-and-coronary-stents-after-2004-operation.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/02/bill-clinton-admitted-for-chest-pain-and-coronary-stents-after-2004-operation.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a88f31a5970b</id>
        <published>2010-02-11T15:00:22-08:00</published>
        <updated>2010-02-11T15:01:19-08:00</updated>
        <summary>Bill Clinton has stents placed in coronary artery Play Video AP – Former Pres. Clinton makes 2nd visit to Haiti From Yahoo.com health report: AP – FILE - In this Dec. 2, 2008 file photo, former U.S. President Bill Clinton...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><div class="hd">
<h1 id="yn-story-title">Bill Clinton has stents placed in coronary artery</h1><a class="provider-logo ult-section" href="http://us.rd.yahoo.com/dailynews/ap/brand/SIG=11f589428/**http%3A%2F%2Fwww.ap.org%2Ftermsandconditions" id="yn-prvdlink"><img alt="AP" class="lzbg " height="27" src="http://l.yimg.com/a/i/us/nws/p/ap_logo_106.png" width="106" /> </a>
<div id="yup-container">
<li class="print last ult-position" />
</div></div>
<div aria-labelledby="yn-story-title" class="bd" role="main">
<div id="yn-story-related-media">
<div class="primary-media yn-style2">
<div class="ult-section yn-style1" id="yn-story-main-media">
<div class="photo-big"><a class="media media3s video" href="http://us.rd.yahoo.com/dailynews/external/ap_av/av_ap3_wl/8ca8c6d1714e5847c76e22885c9ca081/35006674;_ylt=AulkGIeAb2SkbC9LtTgE3RUGw_IE;_ylu=X3oDMTE5OHZ2cmdrBHBvcwMxBHNlYwN5bl9yX3RvcF92aWRlbwRzbGsDZm9ybWVycHJlc2Ns/*http://news.yahoo.com/video/world-15749633/17994111"><img alt="Former Pres. Clinton makes 2nd visit to Haiti" height="160" src="http://d.yimg.com/a/p/ap/20100207/videolthumb.5a96e054e03fc6f925651c41dc27f6eb.jpg?x=213&amp;y=160&amp;xc=1&amp;yc=1&amp;wc=399&amp;hc=300&amp;q=85&amp;sig=Uza4.zaOTf1cZx_6T_DE.w--" width="213" /> <span>Play Video</span> </a><cite class="caption"><a href="/video/world/ap">AP</a>  – Former Pres. Clinton makes 2nd visit to Haiti </cite></div></div>
<p class="ult-position first slideshow"> </p>
<p class="ult-position video">From Yahoo.com health report:</p></div>
<div class="secondary-media ult-section">
<div class="ult-section" id="yn-story-secondary"><a class="media" href="/nphotos/FILE---Dec-2-2008-file-photo-former-US-President/photo//100211/481/d146a7e2ea334bdd8f05e7bfbd069fb2//s:/ap/us_bill_clinton"><img alt="FILE - In this Dec. 2, 2008 file photo, former U.S. President Bill Clinton" height="131" src="http://d.yimg.com/a/p/ap/20100211/capt.d146a7e2ea334bdd8f05e7bfbd069fb2.bill_clinton_xkc114.jpg?x=213&amp;y=131&amp;xc=1&amp;yc=1&amp;wc=410&amp;hc=252&amp;q=85&amp;sig=p.owQ5D.ATUH.2VTiE6wHg--" width="213" /> </a><cite class="caption">AP – FILE - In this Dec. 2, 2008 file photo, former U.S. President Bill Clinton attends the Clinton Global …</cite> </div></div></div>
<div class="byline"><cite class="vcard">By DEEPTI HAJELA, Associated Press Writer <span class="fn org">Deepti Hajela, Associated Press Writer</span> </cite>– <abbr class="recenttimedate" title="2010-02-11T14:28:11-0800">11 mins ago</abbr></div>
<div class="yn-story-content">
<p>NEW YORK – <span class="yshortcuts" id="lw_1265927314_0" style="BORDER-BOTTOM: #0066cc 1px dashed; CURSOR: hand">Former President Bill Clinton</span> had two stents inserted in one of his heart arteries after being hospitalized with <span class="yshortcuts" id="lw_1265927314_1">chest pains</span>, an adviser said Thursday. The adviser, Douglas Band, said Clinton underwent the procedure at <span class="yshortcuts" id="lw_1265927314_2">New York Presbyterian Hospital</span>.</p>
<p>Clinton "is in good spirits and will continue to focus on the work of his foundation and Haiti's relief and long-term recovery efforts," Band said.</p>
<p>Secretary of State Hillary Rodham Clinton left Washington and headed to <span class="yshortcuts" id="lw_1265927314_3">New York</span> to be with her husband.</p><br />
<p>God bless our former President Clinton. He is doing such awesome work with the Clinton Global Initiative and his partnership with American Heart. When will people wake up and understand that their is no definitive treatment of coronary disease.  All of our treatments have a finite durability wheather it's open heart bypass, or percutaneous intervention...if you live long enough it will fail. Done by the best heart surgeon-it seems to be clear that open revasc has better results than PCI even with the newest Drug eluting stent platforms. But I say it again, everything fails. It stands to reason that we all should stop periodically to take a careful survey and reflect if we're doing all possible to "stay off the table". I repeat-do all that is possible to keep the plumbing clean because its a slippery slope. </p>
<p>Sorry for the editorializing. But I guess that's what blogging is for</p></div></div></div>
</content>


    </entry>
    <entry>
        <title>Paul Shirly's Musings</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/paul-shirlys-musings.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/paul-shirlys-musings.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330128771c9061970c</id>
        <published>2010-01-27T13:26:03-08:00</published>
        <updated>2010-01-27T13:26:03-08:00</updated>
        <summary>As you know, this blog is dedicated to vascular devices however when current events assume a prominent position in our lives, it's is hard not to comment on them. That's the great thing about blogging...there are no rules. With that...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>As you know, this blog is dedicated to vascular devices however when current events assume a prominent position in our lives, it's is hard not to comment on them. That's the great thing about blogging...there are no rules. With that in mind-I came across this very controversial article by a former NBA journeyman player, paul shirley. Read it for yourself and reflect. It suggests that in some way, America and other members of our society are enablers to the less fortunate groups of the world. At the very least perhaps it possessess some degree of truth. It is clearly provocative.</p>
<p>I do not know if what I’m about to write makes me a monster. I do know that it makes me a part of a miniscule minority, if Internet trends and news stories of the past weeks are any guide.</p>
<p>“It”, is this:</p>
<p>I haven’t donated a cent to the Haitian relief effort. And I probably will not.</p>
<p>I haven’t donated to the Haitian relief effort for the same reason that I don’t give money to homeless men on the street. Based on past experiences, I don’t think the guy with the sign that reads “Need You’re Help” is going to do anything constructive with the dollar I might give him. If I use history as my guide, I don’t think the people of Haiti will do much with my money either.</p>
<p>In this belief I am, evidently, alone. It seems that everyone has jumped on the  “Save Haiti” bandwagon. To question the impulse to donate, then, will probably be viewed as analogous with rooting for Charles Manson, John Wayne Gacy, or the Spice Girls.</p>
<p>My wariness has much to do with the fact that the sympathy deployed to Haiti has been done so unconditionally. Very few have said, written, or even intimated the slightest admonishment of Haiti, the country, for putting itself into a position where so many would be killed by an earthquake.</p>
<p>I can’t help but wonder why questions have not been raised in the face of this outpouring of support. Questions like this one:</p>
<p>Shouldn’t much of the responsibility for the disaster lie with the victims of that disaster?</p>
<p>Before the reader reaches for his or her blood pressure medication, he should allow me to explain. I don’t mean in any way that the Haitians deserved their collective fate. And I understand that it is difficult to plan for the aftermath of an earthquake. However, it is not outside the realm of imagination to think that the citizens of a country might be able to: A) avoid putting themselves into a situation that might result in such catastrophic loss of life.  And B) provide for their own aid, in the event of such a catastrophe  <a href="http://www.flipcollective.com/2010/01/26/if-you-rebuild-it-they-will-come-by-paul-shirley/" title="read the full article">read more</a></p></div>
</content>


    </entry>
    <entry>
        <title>Bad news for Marine Polymer Technologies?</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/bad-news-for-marine-polymer-technologies.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/bad-news-for-marine-polymer-technologies.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a7c38f6e970b</id>
        <published>2010-01-11T08:22:18-08:00</published>
        <updated>2010-01-11T08:22:18-08:00</updated>
        <summary>I recently blogged on what I feel is a promising new hemostasis agent from Marine Polymer Technologies, the Syvek Patch. We have used the patch and it has performed well as a leave nothing behind agent to achieve puncture site...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        <category scheme="http://www.sixapart.com/ns/types#category" term="Vascular Devices" />
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>I recently blogged on what I feel is a promising new hemostasis agent from Marine Polymer Technologies, the Syvek Patch. We have used the patch and it has performed well as a leave nothing behind agent to achieve puncture site hemostasis-most commonly at the femoral artery. </p>
<p><a href="http://news.moneycentral.msn.com/printarticle.aspx?feed=PZ&amp;date=20091228&amp;id=10946987">From MSN</a>:</p>
<p>Vascular Solutions, Inc. (Nasdaq:VASC) announced that the First Circuit of the U.S. Court of Appeals has affirmed the judgment in its favor in its product disparagement litigation with Marine Polymer Technologies...</p>
<p>This appears to be bad news for a small publicly held company. </p></div>
</content>


    </entry>
    <entry>
        <title> Vascular Surgery -Medical Malpractice Reform...Has the Ship has sailed</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/-vascular-surgery-medical-malpractice-reformhas-the-ship-has-sailed.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2010/01/-vascular-surgery-medical-malpractice-reformhas-the-ship-has-sailed.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b99688330120a7a9ea22970b</id>
        <published>2010-01-06T02:01:00-08:00</published>
        <updated>2010-01-06T02:01:00-08:00</updated>
        <summary>The following is a New York Times article from June 16, 2009. In it President Obama looking to create support for Healthcare reform, speaks of addressing the malpractice issue. No disrespect intended to the Commander-in-Chief (take notes Dick Cheyney) but...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml">The following is a New York Times article from June 16, 2009. In it President Obama looking to create support for Healthcare reform, speaks of addressing the malpractice issue. No disrespect intended to the Commander-in-Chief (take notes Dick Cheyney) but Blah, Blah, Blah. Look where the audacity of hope has landed us this time!!   <nyt_byline type=" " version="1.0" />
<div class="timestamp"> </div>
<div id="articleBody">
<p>It reads: Hoping to enlist support for his campaign for health care reform, President Obama told the American Medical Association this week that he would work with doctors to limit their vulnerability to malpractice lawsuits. That was a reasonable offer — provided any malpractice reform is done carefully.    </p>
<p>Whether malpractice reform would save much money is unclear. Malpractice claims do drive up insurance premiums paid by doctors in some high-risk specialties, such as obstetrics and neurosurgery. Those costs are presumably passed on to patients. There is also concern that doctors may overprescribe costly tests and treatments to avoid possible lawsuits. But the evidence is inconclusive, according to the Congressional Budget Office, that doctors engage in enough “defensive medicine” to have a significant impact on costs. </p>
<p>The office estimates that caps on damages would ultimately reduce malpractice premiums for medical providers but would have a “relatively small” impact on total health spending, reducing it by less than half a percent. Even that could save billions of dollars a year, which is not trivial. But malpractice claims are probably not a major cost driver.</p>
<p>Still, most doctors are convinced that malpractice suits are unfair and burdensome, so it is worth exploring the issue, if only to gain their help in reforming the health care system. Whatever the alternative — tribunals, mediation — patients must retain the right to go to court and seek higher damages than they have been offered. That is the only way to deter negligence by doctors, hospitals and other health care providers...   </p>
<div class="inlineLeft" id="articleInline">
<div id="inlineBox">
<div id="sidebarArticles">I was personally convinced that hopes to control the explosive growth of medical malpractice were all but extinguished until I read this article from Physician News Digest.:</div>
<div> </div>
<div><a href="http://vascularsurgerymedicalexpert.com" title="find a vascular surgery expert">Vascular surgery expert witness</a></div>
<div>
<h2 class="title">CBO Confirms its Support of Med Mal Reform</h2>
<div id="stats"><span>4 January 2010</span> <span /><span>One Comment</span></div>
<div class="entry clearfloat">
<p>Supposing the passage of medical malpractice reform, the Congressional Budget Office (CBO) upped their projected savings to $54 billion from $5 billion over the next 10 years.  Several lawmakers, particularly former ambulance chasers, were not satisfied with the new estimates and asked for more detail.</p>
<p>Last week, the CBO sent an 8-page letter to Rep. Bruce Braley (D-Iowa), who was once the head of Iowa’s trial lawyer association, to answer his concerns about savings and reform would result in loss of care.</p>
<p>The CBO explained that the new estimates are larger, in part, because “they incorporate the effect of a gradual reduction in the utilization of health care services resulting from changes in the practice patterns of providers” such as fewer “defensive medicine” expenses;  and “a proportionately larger reduction in federal spending on health care than in other spending on health care.”</p>
<p>As for any changes in care, no one can answer that one.  The suggestion is that fewer tests may result in poorer outcomes.  However, the reduction of those extra tests, which are potentially unnecessary other than to cover the provider’s liability, would definitely result in savings.  You can read the <a href="http://www.cbo.gov/ftpdocs/108xx/doc10872/12-29-Tort_Reform-Braley.pdf">full letter here.</a></p>
<p>It looks like there still may be some hope....</p>
<p><br /> </p>
<p align="center" class="asset asset-video" style="MARGIN: 0px auto; DISPLAY: block">
<object height="313" width="384"><param name="movie" value="http://www.youtube.com/v/4I_yg1n3Vhs&amp;fs=1" /><param name="allowFullScreen" value="true" /><param name="allowscriptaccess" value="always" />
<embed allowfullscreen="true" allowscriptaccess="always" height="313" src="http://www.youtube.com/v/4I_yg1n3Vhs&amp;fs=1" type="application/x-shockwave-flash" width="384" /></object></p>
<p><br /> </p>
<p><a href="http://vascularsurgerymedicalexpert.com" title="vascular surgery expert witness">vascular surgery expert witness</a></p></div></div></div></div></div></div>
</content>


    </entry>
    <entry>
        <title>Woundcare Complications are source of increasing Malpractice litigation</title>
        <link rel="alternate" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2009/11/woundcare-complications-are-source-of-increasing-malpractice-litigation.html" />
        <link rel="replies" type="text/html" href="http://www.vasculardeviceforum.com/my_weblog/2009/11/woundcare-complications-are-source-of-increasing-malpractice-litigation.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e54ed1b9968833012875c6d32c970c</id>
        <published>2009-11-22T13:30:27-08:00</published>
        <updated>2009-11-22T13:30:27-08:00</updated>
        <summary>I spend a lot of time talking about various vascular devices for revascularization procedures. Unfortunately, a subset of patients will have a failed failed attempt at limb salvage and require amputation. Maybe their disease was too severe at the time...</summary>
        <author>
            <name>lee kirksey</name>
        </author>
        
        
<content type="xhtml" xml:lang="en-US" xml:base="http://www.vasculardeviceforum.com/my_weblog/">
<div xmlns="http://www.w3.org/1999/xhtml"><p>I spend a lot of time talking about various vascular devices for revascularization procedures. Unfortunately, a subset of patients will have a failed failed attempt at limb salvage and require amputation. Maybe their disease was too severe at the time of presentation, perhaps their was aggressive infection or maybe anatomic factors or the patient's medical condition was prohibitive for any attempt at limb salvage. </p>
<p>For numerous reasons, patients will require minor and major amputations of the extremities.  Recent statistics from the <a href="http://www.amputee-coalition.org/fact_sheets/amp_stats_cause.html" target="_blank">National Limb Loss Information Center</a> cite approximately 134,000 annual patient discharges with the diagnosis of limb amputation and the statistic continues to rise. 82% of amputations are related to dysvascular (poor circulation) causes with the rest secondary to cancer or trauma.</p>
<p>Limb loss is trajedty for any patient and presents a source of enormous costs to our healthcare system. These costs include rehabilitation, lost work productivity, nursing home placement and extended care. Importantly, limb amputation is a rising source of malpractice litigation. ment It raises the question of despite the increasing awareness of end users of vascular devices about the prevalence of PAD 1) Are we doing enough to educate the public about treatment options 2) With all of our technology, are we actually increasing the number of people who die with their limb intacts or are we just kicking the can down the road ie delay the inevitable with expensive technology?</p>
<p><a href="http://www.pennmedicine.org/woundcare/">find a physician woundcare expert at the Penn Woundcare Center</a></p>
<p><a href="http://www.seakexperts.com/members/2102-lee-kirksey" target="_blank">physician expert testimony</a></p>
<div class="page-title title">
<h2>Wound Care: The Challenges Continue as Litigation Increases</h2></div>
<div class="node ntype-article clear-block" id="node-3116">
<div class="content">
<div class="node-body">
<p><em>Glenda Motta, RN, MPH, ET</em></p>
<p>It continues to amaze me how many new products and wound-related treatments enter the market each year. The options for preventing and treating most skin and wound conditions have expanded dramatically. Yet the question still remains: Has wound care improved?<br /></p>
<p>You are likely to answer “no” to that question if you use litigation related to wound care as an indicator. My associates and I have reviewed a record number of cases involving negative outcomes related to wound care. Most often, limb amputation or death from sepsis is the end result of the care provided. Our opinions, provided to attorneys for both plaintiffs and defendants, reveal a striking pattern. The breach of the standard of care is more often related to facility staffing, policies, and procedures than to the actual treatment or products used on the wounds.<br /></p>
<p>Facilities with well-defined policies for prevention, assessment, and intervention most often provide documentation that supports care rendered and its outcomes. Negative patient outcomes are more apt to occur in facilities with weak or outdated policies, poor wound care education, and inadequate staffing. In many cases that we review, the patient has been hospitalized multiple times and transferred to four or more different long-term care facilities.<br /></p>
<p>The most astonishing phenomenon is the lack of knowledge regarding basic wound care. We might assume that nurses are routinely trained in this area, but evidence proves that this is not the case. Even when staffing includes a wound care expert, the attitude of nurses is “that’s not my job.” Consequently, wound care is not incorporated into the general nursing care provided on a daily basis. <br /></p>
<p>Litigation continues to increase as a result of consumer awareness. Families see the wound develop, question why and how this happened, often get little or no response from staff, and then get angry. The anger results in a visit to an attorney.<br /></p>
<p>At the same time, the federal government is increasing its monitoring of care provided to individuals in institutions, particularly those where negative outcomes have been reported. More than 20 nursing home cases have been prosecuted under the False Claims Act, in which the government claims that a provider knowingly billed for substandard health care services. These substandard services result in actual harm to residents, such as malnutrition, dehydration, multiple pressure ulcers, amputations, or death.<br /></p>
<p>The government initiates an investigation of negative outcomes when any of the following occur in an institution: death from any cause, bone fractures, pressure ulcer development and deterioration, malnutrition/significant weight loss, dehydration, development of infection, severe burns, or severe drug reactions. <br /></p>
<p>Sanctions imposed on facilities under investigation include denial of payment for new admissions, denial of payment for all Medicare/Medicaid residents, civil monetary penalties per day and per incident, appointment of a temporary manager, and termination of Medicare/Medicaid provider agreements. Several cases have resulted in closure of the facility, relocation of the residents, referral of nurses and physicians to licensing boards for sanction, and criminal prosecution for deaths related to substandard wound care.<br /></p>
<p>So, with the threat of increased litigation looming, and more importantly, with all the resources available to prevent and treat alterations in skin integrity and chronic wounds as well as to treat wounds appropriately, why aren’t we seeing better outcomes? In many cases, we spend more and achieve less. After all these years, why aren’t we getting the message out and into clinical practice? <br /></p>
<p><em>Glenda Motta, RN, MPH, ET is president and CEO of GM Associates, Inc., a nationally recognized leader in reimbursement strategic planning and problem solving, clinical research, education, marketing, and sales support.</em></p></div></div></div></div>
</content>


    </entry>
 
</feed><!-- ph=1 --><!-- nhm:dynamic-ssi -->
